Swissmedic authorises new drug for respiratory disease

Swiss drugs reglator Swissmedic has authorised a new medicine to treat colds and cases of acute bronchitis in infants and young children. Beyfortus is used to treat respiratory tract diseases caused by the respiratory syncytial virus (RSV).

The step was taken “after careful consideration”, Swissmedic said on Thursday. It is an important step towards prophylaxis against RS viruses, a common cause of respiratory diseases, a Swissmedic spokesperson told the Swiss News Agency Keystone-SDA. ...